肝纤维化细胞外容积分数成像:CT与MRI应用及证据
本文综述CT与MRI来源的肝细胞外容积分数在肝纤维化及相关慢性肝病中的临床前与临床证据,聚焦计算方法、生物学解释及其与组织病理和部分临床结局的相关性。同时讨论异质性来源、解读限度及证据缺口。
要点
- 肝ECV可无创反映纤维化重塑相关的细胞外间隙扩大,可作为多参数肝脏影像的补充。
- 临床解读ECV时需注意不同测量方案与患者因素带来的异质性。
- 目前证据尚不足以支持肝ECV单独替代活检或弹性成像进行分期。
核心结论
- ECV是一种有前景的无创定量影像生物标志物,可用于评估肝纤维化相关细胞外间隙扩大。
- 在更广泛整合为多参数肝脏影像补充组分前,仍需解决证据缺口与解读限度。
研究设计与样本
- 本文为综述,汇总肝ECV成像的临床前与临床资料,涉及CT及MRI来源的计算方法与证据。
关键影像表现/征象
- 肝ECV升高可反映纤维化重塑相关的细胞外间隙扩大,是影像可量化的组织特征。
临床应用与阅片要点
- 肝ECV可作为多参数肝脏影像的补充组分,辅助慢性肝病预后分层与治疗计划制定。
- 阅片时应关注ECV计算方法与扫描方案差异,避免将数值直接跨机构比较。
局限性
- 现有证据存在明显异质性,包括计算方法、扫描参数与患者人群差异。
- 关键解读限度与证据缺口尚未解决,未达到广泛临床整合条件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Accurate diagnosis and staging of liver fibrosis are essential for prognostic stratification and treatment planning in chronic liver disease. However, conventional approaches for diagnosing and monitoring fibrosis, such as biopsy, elastography and serum-based scores, are limited by invasiveness, sampling variability, or performance in early-stage disease. Extracellular volume fraction (ECV) has emerged as a promising non-invasive quantitative imaging biomarker for assessing extracellular space expansion associated with hepatic fibrotic remodeling. In this review, we summarize current preclinical and clinical data on computed tomography (CT-) and magnetic resonance imaging (MRI)-derived ECV in liver fibrosis and related chronic liver diseases, with a focus on calculation methods, biologic interpretation, and correlations with histopathology and selected clinical outcomes. We also discuss major sources of heterogeneity, key interpretive limitations, and the evidence gaps that must be addressed before hepatic ECV can be more broadly integrated as a complementary component of multiparametric liver imaging.
引用
- Qi, Chi, Xu, et al. Extracellular Volume Fraction Imaging for Hepatic Fibrosis: CT and MRI Implementation and Evidence. Acad Radiol. 2026. PMID: 42680654. doi:10.1016/j.acra.2026.06.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。